Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05539326 · ClinicalTrials.gov registry record
A Study of the Construct Validity of Community Walking Speed Data Collected Remotely With the Canary canturioTM te Tibial Extension
A clinical trial of Osteoarthritis, Knee, sponsored by Canary Medical.
- Completed
- Registry status
- 52
- Enrollment target
- 6
- Study locations
NCT05539326: Completed study of Osteoarthritis, Knee, sponsored by Canary Medical.
NCT05539326 is a study of Osteoarthritis, Knee that has completed, run by Canary Medical. The registered enrollment target is 52 participants, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (90% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05539326, a study of Osteoarthritis, Knee, has completed, sponsored by Canary Medical.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to determine the construct validity of the Canary Tibial Extension's measure of self-selected community walking speed. Construct validity will be assessed by the Pearson's correlation coefficient between self-selected community walking speed and the 4-meter walk test. The objective of this multicenter, prospective study is to demonstrate that remote measurement of community walking speed with the Canary canturioTM (CTE) tibial extension is correlated with the fast 4-meter walk test (4mWT).
Primary Outcome
A 4MWT test will be performed in the physician's clinic along a clear pathway of at least 8 in length in a designated area over solid flooring. The 8-m distance will be measured with a starting (0m) and an end point (8m) with additional marks at 2m and 6m to identify the 4m which is the timed portion of the test. A handheld, calibrated stopwatch will be used as the gold standard for measuring walking speed output during the 4 mWT, measuring the time it takes to complete the test.
Conditions Studied
Interventions
- OTHER Performance Clinical Outcome Test
Study Locations (6)
Colorado
- Vail Summit Orthopaedics and Neurosurgery - Frisco
Indiana
- South Bend Orthopaedics - South Bend
Mississippi
- Mississippi Sports Medicine and Orthopaedic Center - Jackson
New Jersey
- Orthopedic NJ - Sparta
Oregon
- Dr. Ballard - Oregon City
Texas
- Orthopaedic Surgery and Sports Medicine - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2022-12-29 |
| Est. Completion | 2023-05-12 |
What the finished NCT05539326 record still lists
NCT05539326 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which Performance Clinical Outcome Test is the first listed.
NCT05539326 lists 6 locations in 6 states (Colorado, Indiana, Mississippi).
Frequently Asked Questions
What is clinical trial NCT05539326 about?
NCT05539326 is a clinical study titled "A Study of the Construct Validity of Community Walking Speed Data Collected Remotely With the Canary canturioTM te Tibial Extension". The purpose of this study is to determine the construct validity of the Canary Tibial Extension's measure of self-selected community walking speed. Construct validity will be assessed by the Pearson's correlation coefficient between self-selected community walking speed and the 4-meter walk test. Th...
What is the current status of trial NCT05539326?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2022-12-29. Estimated completion is 2023-05-12.
What conditions does trial NCT05539326 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT05539326?
The interventions under investigation include: Performance Clinical Outcome Test (OTHER).
Who is sponsoring clinical trial NCT05539326?
This trial is sponsored by Canary Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05539326 being conducted?
This trial has 6 study locations across Colorado, Indiana, Mississippi, New Jersey, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05539326's enrollment target sits among peer trials
52 89th of 112 higher than 24 of 112 other Osteoarthritis, Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
RECRUITING · Phase 3
-
Mobilizing Hispanics With Knee Osteoarthritis
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
The Osteoarthritis Prevention Study
RECRUITING · NA
-
Preventing Injured Knees From osteoArthritis: Severity Outcomes
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI